Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
12.02
+0.03 (0.25%)
May 2, 2025, 10:45 AM EDT - Market open

Dyne Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
1,3662,398816604606954
Upgrade
Market Cap Growth
193.72%193.72%35.12%-0.32%-36.50%-
Upgrade
Enterprise Value
7741,699687387233585
Upgrade
Last Close Price
11.9923.5613.3011.5911.8921.00
Upgrade
PB Ratio
1.953.818.942.391.652.79
Upgrade
P/TBV Ratio
2.213.818.942.391.652.79
Upgrade
Debt / Equity Ratio
0.040.040.300.120.09-
Upgrade
Quick Ratio
15.2015.202.419.1213.1131.49
Upgrade
Current Ratio
15.6015.602.539.4613.3131.83
Upgrade
Return on Equity (ROE)
-88.03%-88.03%-137.31%-54.18%-42.02%-33.35%
Upgrade
Return on Assets (ROA)
-50.20%-50.20%-64.21%-29.20%-24.07%-19.82%
Upgrade
Return on Capital (ROIC)
-55.64%-55.64%-75.38%-31.26%-25.23%-20.57%
Upgrade
Earnings Yield
-22.80%-13.24%-28.90%-27.82%-24.63%-6.23%
Upgrade
FCF Yield
-21.17%-12.29%-23.14%-25.94%-20.33%-5.00%
Upgrade
Buyback Yield / Dilution
-57.74%-57.74%-14.83%-2.13%-253.54%-489.30%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q